OSN New York Retina Meeting

Program

8:00 am – 9:00 am

Breakfast Seminar

9:00 am – 9:05 am

Welcome Message
Rishi P. Singh, MD

9:05 am – 10:10 am

Retinal Surgery
Session Chairs: Ronald C. Gentile, MD, FACS, FASRS; Paul Hahn, MD, PhD

Pretest

Management of the Retained Lens Fragment
Andrew A. Moshfeghi, MD, MBA

Aphakia and IOL Dislocation Management
Anton Orlin, MD

Techniques for PVR Surgery and When to Retinectomy
Ronald C. Gentile, MD, FACS, FASRS

When to go Fancy (and When NOT to) in Macular Hole Surgery
Yasha S. Modi, MD

Panel Discussion/Q&A

10:10 am – 10:25 am

Exhibit Hall Break

10:25 am – 11:40 am

Retinal Surgery (Continued)
Session Chairs: Ronald C. Gentile, MD, FACS, FASRS; Paul Hahn, MD, PhD

Treatment Patterns of Retinal Detachment Repair: The Friday Syndrome?
Prithvi Mruthyunjaya, MD, MHS

Lamellar Holes: When to Intervene and When to Observe
Stanley Chang, MD

Complex Tractional Retinal Detachments in Diabetics: Pearls and Outcomes
Dimitra Skondra, MD, PhD

An Update on 3D and Intraoperative OCT in Retinal Surgery
Lejla Vajzovic, MD

Chromovitrectomy: The Old and the New
Paul Hahn, MD, PhD

Discussion, Q&A and Posttest

11:40 am – 12:15 pm

Case Conference: Retinal Surgery
Session Chairs: Donald J. D’Amico, MD; Kenneth J. Wald, MD
Session Panel: Royce W. S. Chen, MD; Peter E. Weseley, MD

12:15 pm – 12:20 pm

Break

12:20 pm – 1:20 pm

CME Lunch Seminar: Eye On Expanding Surgical Systems That Lengthen Treatment Intervals in nAMD and DME

  • Supported by an educational grant from Genentech, a member of the Roche Group

Introduction and Pre-test
Carl C. Awh, MD

Innovative Surgical Delivery Systems that Extend AMD and DME Treatment Intervals
Jordan M. Graff, MD

  • Port delivery system with ranibizumab
    • Current status of clinical trials on efficacy and safety PDS
  • Gene therapy
    • Current status of clinical trials for RGX314 for nAMD, GT005 for dry AMD, and ADVM-022 for nAMD and DME

Minimizing Complications through Effective Surgical Techniques
Carl C. Awh, MD

  • RGX-314 surgical techniques: pearls and pitfalls
  • Surgical techniques for PDS, updates to surgery, refill techniques, pearls and pitfalls. To include:
    • Laser ablation techniques to treat choroid to avoid vitreous hemorrhage
    • Best practices and procedures that can reduce complications with the PDS including the use of a thorough preoperative evaluation, as well as optimizing conjunctival peritomy, closure and suture management, scleral incision, and working with fragile tissues

Posttest and Q&A

1:20 pm – 1:35 pm

Exhibit Hall Break

1:35 pm – 3:00 pm

Diabetic Retinopathy and Diabetic Macular Edema
Session Chair: Anton Orlin, MD; Rishi P. Singh, MD

Pretest

Are Diabetic Retinopathy Practice Patterns Really Impacted by Clinical Trials?
Prithvi Mruthyunjaya, MD, MHS

Imaging in DR: Biomarkers in DR and DME Treatment
Rishi P. Singh, MD

Emerging Therapies in the Treatment of DR and DME
Avnish Deobhakta, MD

Ultrawidefield Fundus Imaging and Application to Diabetic Retinopathy
Szilard Kiss, MD

Ang-2 Inhibition in the Management of DME
Jonathan Jonisch, MD

What Happens to DR Stage When You Stop Anti-VEGF Therapy
Sophie J. Bakri, MD

Discussion/Q&A

3:00 pm – 3:35 pm

Case Conference: Retinal Vascular Disease
Session Chairs: Prithvi Mruthyunjaya, MD, MHS; Lawrence A. Yannuzzi, MD
Session Panel: Talia R. Kaden, MD; Nitish Mehta, MD; Thanos Papakostas, MD

3:35 pm – 3:55 pm

Exhibit Hall Break

3:55 pm – 5:20 pm

OSN’s Disruptive Innovations Symposium**
The Latest Advances in Diagnostics, Drug Delivery and Surgical Devices

5:20 pm – 6:00 pm

Meet the Faculty Reception*

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York Retina 2021 or its accredited provider.

8:00 am – 9:00 am

Industry Expert Theater Breakfast

  • Presented by Apellis
9:00 am – 9:15 am

Exhibit Hall Break

9:15 am – 11:00 am

Age-related Macular Degeneration
Session Chairs: Sophie J. Bakri, MD; Rishi P. Singh, MD

Announcements and Pretest

Submacular Hemorrhage: Clinic or OR? What Does the Data Support?
Sophie J. Bakri, MD

AI for Detecting AMD and Progression of Disease
Rishi P. Singh, MD

Sustained Drug Delivery for AMD
Jorge A. Fortun, MD

Assessing OCT Biomarkers for Geographic Atrophy
Nitish Mehta, MD

Emerging Therapies for the Treatment of GA
Caroline R. Baumal, MD

Gene Therapy for Exudative AMD
Cagri G. Besirli, MD, PhD

What Does Metformin Have to do with AMD? More Than You Think
Dimitra Skondra, MD, PhD

Optimizing Workflow in Retina Clinic
Caroline R. Baumal, MD

Discussion, Q&A and Posttest

11:00 am – 11:15 am

Exhibit Hall Break

11:15 am – 11:50 am

Case Conference: Macular Disease
Session Chairs: Caroline R. Baumal, MD; Yasha S. Modi, MD
Session Panel: Eric D. Nudleman, MD, PhD; David Sarraf, MD; Rishi P. Singh, MD

11:50 am – 12:05 pm

Break

12:05 pm – 1:05 pm

Industry Expert Theater Lunch: Early Identification and Management Strategies for Patients With DME

  • Presented by Allergan, an AbbVie company.
    Jorge Fortin, MD; Lejla Vajzovic, MD
1:05 pm – 1:20 pm

Exhibit Hall Break

1:20 pm – 2:55 pm

Imaging
Session Chairs: Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA; Nitish Mehta, MD

Pretest

Epiretinal Membrane: Mechanisms in the Development and Progression using Advanced Retinal Imaging
David Sarraf, MD

Non-perfusion (and Reperfusion) with Anti-VEGF Management in DR
Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA

How Imaging Helps Me Diagnose and Follow Patients with Uveitis
Yasha S. Modi, MD

Polypoidal Choroidal Vasculopathy and the Pachychoroid Spectrum
Lawrence A. Yannuzzi, MD

OCT and OCTA Biomarkers in AMD: What Should We Take Back to the Clinic
Thanos Papakostas, MD

Defining the Role of OCTA in AMD
David Sarraf, MD

Widefield OCT: What, How, and Now
Andrew A. Moshfeghi, MD, MBA

Discussion, Q&A and Posttest

2:55 pm – 3:30 pm

Case Conference: How Imaging Helped to Seal the Diagnosis
Session Chair: Yasha S. Modi, MD; Eric D. Nudleman, MD, PhD
Session Panel: Thanos Papakostas, MD; David Sarraf, MD

3:30 pm – 3:40 pm

Break

3:40 pm – 4:30 pm

Controversies in Care
Session Chairs: Lejla Vajzovic, MD; Peter E. Weseley, MD

Epiretinal Membranes: Early Treatment or Watchful Waiting
Meenakashi Gupta, MD

Fovea-Sparing Rhegmatogenous RD Repair Timing: Is it an Emergency?
Talia R. Kaden, MD

Complete vs. Limited Vitreous Shaving for RRD Repair: What is Necessary?
Lejla Vajzovic, MD

Why Do We Even Talk About Fluid in AMD?
Darius M. Moshfeghi, MD

Discussion and Q&A

4:30 pm – 5:30 pm

Business of Retina and Practice Management
Session Chairs: Vaidehi S. Dedania, MD; Philip J. Ferrone, MD

Private Equity in Retina: Evaluating the PE Model
Philip J. Ferrone, MD

Has COVID-19 Changed the Practice of Retina (Forever)?
Darius M. Moshfeghi, MD

Retina Practice Implementation of E/M Changes and Guidelines
Mary Pat Johnson, COMT, CPC, COE, CPMA

Discussion/Q&A

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York Retina 2021 or its accredited provider.

8:00 am – 9:00 am

CME Breakfast Seminar: Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: A New Approach to Treatment

  • Supported by an educational grant from Genentech, a member of the Roche Group
    Moderator: Rishi P. Singh, MD
    Faculty: David Eichenbaum, MD

Introduction and Pre-test
Rishi P. Singh, MD

The Role of Angiopoietins in Vascular Stability and Instability in Retinal and Choroidal Vascular Diseases
David Eichenbaum, MD

  • Understanding how Ang 1 Tie2 promotes vascular stability and maintains homeostasis, while Ang 2 Tie2 drives vascular instability

Targeting Angiopoietin-2 in Retinal and Choroidal Vascular Diseases: Emerging Injectables
Rishi P. Singh, MD

  • Review of clinical trials for razuprotafib, faricimab, and potential for AXT107

Posttest and Q&A
All Faculty

9:00 am – 10:00 am

Pediatric Retina
Session Chairs: Cagri G. Besirli, MD, PhD; Vaidehi S. Dedania, MD; Eric D. Nudleman, MD, PhD

Announcements and Pretest

RD Repair in Self-inflicted Trauma
Vaidehi S. Dedania, MD

Anti-VEGF for ROP: Role of Adjunct Laser
Cagri G. Besirli, MD, PhD

Pediatric Retinal Conditions Seen in Adults
Eric D. Nudleman, MD, PhD

Cases in Pediatric Retina and Q&A

10:00 am – 10:20 am

Exhibit Hall Break

10:20 am – 11:40 am

Uveitis
Session Chairs: Yasha S. Modi, MD; Sunil K. Srivastava, MD

Vitreoretinal Lymphoma: When to Suspect This and How to Diagnose
Prithvi Mruthyunjaya, MD, MHS

How to NOT Miss Infectious Uveitis
Sunil K. Srivastava, MD

Preventing Endophthalmitis After Intravitreal Injection: What Do We Know
Vaidehi S. Dedania, MD

Uveitis for the Retina Surgeon: When to Intervene and When to Treat in the Clinic
Sunil K. Srivastava, MD

New Directions for Local Control of Intraocular Inflammation
Jorge A. Fortun, MD

Systemic Therapy for Uveitis: Considerations for use during COVID-19
Sunil K. Srivastava, MD

Discussion, Q&A and Posttest

11:40 am – 12:40 pm

CME Seminar: Targeting of the Complement System in Geography Atrophy: New Insights and Emerging Options for Treatment

  • Supported by an educational grant from Apellis
    Moderator: Caroline Baumal, MD
    Faculty: Nathan C. Steinle, MD

Introduction and Pretest
Moderated by Caroline Baumal, MD

Assessing the Role of Complement in AMD
Caroline Baumal, MD

  • Pathophysiology and the Role of Complement in AMD
    • Physiology of complement cascade activation - antibody-dependent, antibody-independent, and lectin pathways
    • Mechanism behind complement inhibition and effects on cell degeneration and death – C3, C5, MAC
  • Discussion of previous agents for the treatment of GA: Eculizumab, LFG316, Lampalizumab, etc

Emerging Options that Target the Complement Cascade
Nathan C. Steinle, MD

  • Emerging options that target the complement cascade in dry AMD and GA
  • Review of clinical trial data on safety and efficacy for avacincaptad pegol, POT-4, APL-2 (pegcetacoplan), HMR59

Posttest and Q&A
All Faculty

12:40 pm – 1:15 pm

Case Conference: Uveitis
Session Chair: Sunil K. Srivastava, MD
Session Panel: Yasha S. Modi, MD; David Sarraf, MD

1:15 pm

Closing Remarks & Lunches to Go

*These sessions are not approved for AMA PRA Category 1 Credit(s)™.
**These sessions are not approved for AMA PRA Category 1 Credit(s)™ and are neither provided by nor endorsed by OSN New York Retina 2021 or its accredited provider.